QUALITY ASSESSMENT OF CD34(-CELL ENUMERATION - EXPERIENCE OF THE INGDOM-NATIONAL-EXTERNAL-QUALITY-ASSESSMENT-SCHEME (UK NEQAS) USING A UNIQUE STABLE WHOLE-BLOOD PREPARATION() STEM)
D. Barnett et al., QUALITY ASSESSMENT OF CD34(-CELL ENUMERATION - EXPERIENCE OF THE INGDOM-NATIONAL-EXTERNAL-QUALITY-ASSESSMENT-SCHEME (UK NEQAS) USING A UNIQUE STABLE WHOLE-BLOOD PREPARATION() STEM), British Journal of Haematology, 102(2), 1998, pp. 553-565
CD34(+) peripheral blood stern cell (PBSC) mobilization and harvesting
has rapidly replaced autologous bone marrow as a source of stem cells
for transplantation. Timing and adequacy of harvests rely upon the ac
curate enumeration of circulating CD34+ cells, However, previous EQA p
rogrammes have reported interlaboratory CVs as high as 284%, suggestin
g the need for greater standardization. In addition the routine use of
fresh and/or frozen cells as analytes also introduces antigen instabi
lity as a variable factor, To circumvent this problem and achieve a tr
ue reflection of interlaboratory variation, we have used a novel whole
blood preparation in which the antigenic profiles of PBSCs, as determ
ined by flow cytometry, are retained for > 200 d. This international s
cheme, currently the largest in the world, distributes aliquots of sta
bilized whole blood bi-monthly to 91 laboratories in 20 countries (44
U.K., 47 overseas). Participants are required to determine the percent
age and absolute values for CD34+ PBSCs using in house techniques. Ado
pting such a preparation, a more accurate determination of interlabora
tory variation has been possible when compared to previous EQA studies
, with CVs as low as 22% and 24% for percentage and absolute counts. I
n addition the programme has established that a wide range of methods
are in routine use, emphasizing the urgent requirement for national/in
ternational consensus guidelines.